免疫检查点抑制剂诱导的心肌炎的药物治疗
Yihao Wu1, Yizhou Xu1, Linhao Xu1,2
1Department of Cardiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Frontiers in pharmacology
|June 12, 2023
概括
免疫检查点抑制剂可以改善癌症的存活率,但可能导致罕见的,严重的心脏损伤. 本综述探讨了ICI心脏毒性机制,临床效应和新兴治疗方法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI),如CTLA-4,PD-1和PD-L1,可以提高癌症患者的生存率.
- 然而,ICI可以诱导心脏毒性,这是一种罕见但严重的并发症,死亡率高.
- 了解ICI介导的心血管毒性对于患者管理至关重要.
研究的目的:
- 审查ICI诱导心脏毒性的机制和临床表现.
- 总结目前ICI相关心肌炎的治疗策略.
- 探索新的治疗方法来管理ICI心脏毒性.
主要方法:
- 对ICI心脏毒性研究的文献综述.
- 对涉及ICI诱导心肌炎的信号通路的分析.
- 对ICI相关心肌炎治疗的临床试验摘要.
主要成果:
- 多种信号通路有助于ICI诱导的心肌炎.
- 目前用于ICI相关心肌炎的治疗方法显示出一些益处,但不是最佳的.
- 新型化合物显示出治疗ICI心脏毒性的治疗潜力.
结论:
- ICI心脏毒性是一个重大问题,需要进一步研究.
- 优化当前的治疗方法和探索新疗法是必不可少的.
- 了解潜在的机制可以指导未来的治疗发展.
更多相关视频
相关概念视频
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction
10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Pericarditis III: Medical Management
16
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
16
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18


